• Mithra will hold a joint symposium with partner Gedeon Richter on October 11
• Four leading experts will explain why estrogen plays a vital role in contraception and the treatment of post-menopausal symptoms
• Data shows promising safety and efficacy characteristics for E4, key active ingredient in ESTELLE® and DONESTA®
Liège, Belgium, October 10, 2023 – 6:00 p.m. CEST – Mithra (Euronext Brussels: MITRA), a company specializing in women’s health, will give four presentations on the role of estrogens (including its native estrogen Estetrol (E4)) at a symposium at the World Congress of the International Federation of Gynecology and Obstetrics (FIGO), which will be held from October 9 to 12 in Paris.
The Oct. 11 symposium, which Mithra is co-hosting with partner Gedeon Richter Plc., will highlight why estrogen is essential in contraception and for postmenopausal women. Estrogen plays an important role in many organs and tissues and is essential for regulating the female reproductive system and secondary sexual characteristics. Estrogen is at the heart of women’s health thanks to its complex action and its role in the regulation of multiple functions.